Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lung cancer
lung cancer
Roche builds case for TIGIT combo in untreated lung cancer
Pharmaforum
Fri, 12/10/21 - 10:50 am
Roche
anti-TIGIT
tiragolumab
Tecentriq
lung cancer
Bristol Myers adds to neoadjuvant win for Opdivo in lung cancer, escalating early cancer showdown with Merck
Endpoints
Mon, 11/8/21 - 10:58 am
Bristol Myers Squibb
Merck
Opdivo
lung cancer
Keytruda
Takeda launches value-based pricing program for lung cancer med Alunbrig, promises more deals to come
Fierce Pharma
Mon, 11/8/21 - 10:54 am
Takeda
Alunbrig
value-based pricing
drug pricing
lung cancer
Novartis hits another setback in plan to repurpose rare disease drug in lung cancer
BioPharma Dive
Mon, 10/25/21 - 11:51 pm
Novartis
clinical trials
canakinumab
Ilaris
lung cancer
Calithera buys itself a plan B
EP Vantage
Tue, 10/19/21 - 10:43 am
Calithera Biosciences
Takeda
telaglenastat
sapanisertib
mivovatinib
lung cancer
B cell lymphoma
Bayer teams up with Huma to apply AI to lung cancer diagnosis
Pharmaforum
Wed, 09/29/21 - 11:57 pm
Bayer
artificial intelligence
Huma
digital health
lung cancer
diagnostics
AstraZeneca touts Imfinzi immunotherapy combos for lung cancer in push to drive PD-L1 drug uptake
Endpoints
Fri, 09/17/21 - 10:58 am
AstraZeneca
Imfinzi
lung cancer
Takeda gets a win for its Wave1 pipeline, as Exkivity nabs FDA approval
Pharmaforum
Thu, 09/16/21 - 10:44 am
Takeda
FDA
lung cancer
Exkivity
World Lung 2021 – front-line competition lines up behind Keytruda
EP Vantage
Tue, 09/14/21 - 10:43 am
World Lung
Merck
Keytruda
CStone Pharmaceuticals
Shanghai Junshi Biosciences
lung cancer
Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?
Motley Fool
Fri, 08/27/21 - 10:54 am
CureVac
Boehringer Ingelheim
MRNA
lung cancer
vaccines
Moderna Therapeutics
BioNTech
J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech
Pharmaforum
Thu, 08/26/21 - 08:42 pm
JNJ
Optellum
digital biomarker
lung cancer
artificial intelligence
Regeneron drug extends survival in lung cancer trial, lifting company's hopes in field
BioPharma Dive
Thu, 08/5/21 - 11:02 pm
Regeneron
Sanofi
Libtayo
clinical trials
lung cancer
Merck KGaA’s targeted lung cancer drug tepotinib wins early access in UK
Pharmaforum
Thu, 07/15/21 - 12:29 pm
Merck KGaA
lung cancer
UK
tepotinib
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
clinical trials
Merck
Ridgeback Biotherapeutics
COVID-19
Intellia Therapeutics
transthyretin amyloidosis
Arcus Biosciences
Gilead Sciences
lung cancer
Sanofi
GSK
vaccines
uniQure
Huntington's disease
Mirati Therapeutics
gene editing
Seres Therapeutics
ulcerative colitis
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Takeda fleshes out case for oral EGFR drug with follow-up pivotal data in non-small cell lung cancer
Endpoints
Wed, 05/19/21 - 11:14 pm
ASCO 2021
lung cancer
Takeda
FDA
non-small cell lung cancer
Nuvalent bags $135M to trial resistance-beating kinase inhibitors in lung cancer
Fierce Biotech
Tue, 05/11/21 - 11:05 am
Nuvalent
funding
lung cancer
Takeda earns win for its TKI inhibitor in tiny lung cancer group — but GI side effects could be an early red flag
Endpoints
Thu, 01/28/21 - 10:41 am
Takeda
lung cancer
mobocertinib
non-small cell lung cancer
Closely Watched Mirati Reveals Results to Rival Amgen Drug
Bloomberg
Sun, 10/25/20 - 11:30 pm
Mirati Therapeutics
Amgen
adagrasib
lung cancer
Flame Biosciences to Ignite Pipeline with $100M Common Stock Financing
BioSpace
Thu, 10/1/20 - 11:15 pm
Flame Biosciences
lung cancer
BridgeBio's Navire preps SHP2 blocker for lung cancer trial after positive mouse study
Fierce Biotech
Mon, 09/14/20 - 10:14 am
Bridge Bio
Navire Pharma
lung cancer
clinical trials
IACS-13909
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »